Xu Yang

Xu Yang

Associate Researcher, PhD

Publications

Journal Articles

Poor recognition and undertreatment of anemia in patients with chronic kidney disease managed in primary care.

Published in Journal of Internal Medicine, 2023

Background

Anemia is a common complication of chronic kidney disease (CKD), but limited awareness and treatment options may hinder its management among CKD patients followed in primary care.

Recommended citation: Xu Y*, Evans M, Mazhar F, et al.(2023). "Poor recognition and undertreatment of anemia in patients with chronic kidney disease managed in primary care." Journal of Internal Medicine. 2023;00:1-12.
Download Paper

Long-term Visit-to-Visit Variability in Hemoglobin A(1c) and Kidney-Related Outcomes in Persons With Diabetes.

Published in American Journal of Kidney Diseases, 2023

Rationale & Objective

To characterize associations between long-term visit-to-visit variability of hemoglobin A1c (HbA1c) and risk of adverse kidney outcomes in patients with diabetes.

Recommended citation: Xu Y*, Dong S, Fu EL, Sj？lander A, Grams ME, Selvin E, Carrero JJ(2023). "Long-term Visit-to-Visit Variability in Hemoglobin A(1c) and Kidney-Related Outcomes in Persons With Diabetes." American Journal of Kidney Diseases. 2023;82(3):254-256.
Download Paper

National incidence and mortality of hospitalized sepsis in China.

Published in Critical Care, 2023

Background

Sepsis is a leading cause of preventable death around the world. Population-based estimation of sepsis incidence is lacking in China. In this study, we aimed to estimate the population-based incidence and geographic variation of hospitalized sepsis in China.

Recommended citation: Weng L#, Xu Y#, Yin P#, Wang Y, Chen Y, Liu W, Li S, Peng JM, Dong R, Hu XY, Jiang W, Wang CY, Gao P, Zhou MG, Du B and for the China Critical Care Clinical Trials G.(2023). "National incidence and mortality of hospitalized sepsis in China. " Critical Care. 1(3).
Download Paper

Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes.

Published in American heart journal, 2022

Background

Stopping renin-angiotensin system inhibitors (RASi) after an episode of hyperkalemia is common but may involve therapeutic compromises, in that the cessation of RASi deprives patients of their beneficial cardiovascular effects.

Recommended citation: Xu Y*, Fu EL, Trevisan M, Jernberg T, Sj？lander A, Clase CM, Carrero JJ. (2022). "Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes. " American heart journal. 2022;243:177-186.
Download Paper

Burden and causes of hospital admissions and readmissions in patients undergoing hemodialysis and peritoneal dialysis a nationwide study.

Published in American heart journal, 2021

Background

High rates of hospitalization in dialysis patients impose an increasing healthcare burden. We explored and compared hospital admission rates among patients starting hemodialysis (HD) and peritoneal dialysis (PD), and investigated causes of admission/readmission in search of potentially preventable risks.

Recommended citation: Xu Y#, Li L#, Evans M, Xu H, Lindholm B, Carrero JJ. (2021). "Burden and causes of hospital admissions and readmissions in patients undergoing hemodialysis and peritoneal dialysis a nationwide study. " Journal of nephrology. 2021;34:1949-1959.
Download Paper